• Innovative ROS Quantification: Leveraging the DCFH-DA Assay

  2026-07-05

  Explore the science and advanced applications of the Reactive Oxygen Species Assay Kit for precise oxidative stress measurement. This article offers unique technical insights and practical assay guidance for cellular ROS quantification in cancer and cell biology research.

• Bifendate Inhibits Autophagy and Reduces Lipid Accumulation

  2026-07-04

  This study reveals that bifendate (DDB), a clinically used hepatoprotective agent, inhibits autophagy at multiple steps and reduces oleic acid-induced lipid droplet accumulation in cultured cells. The findings clarify DDB's mechanisms in modulating lysosomal function and lipid metabolism, opening paths for further research in hepatic disease models.

• FITC Goat Anti-Rabbit IgG (H+L) Antibody: Precision in Fluor

  2026-07-03

  The FITC Goat Anti-Rabbit IgG (H+L) Antibody delivers robust, reproducible fluorescence-based detection of rabbit primary antibodies across immunofluorescence, flow cytometry, and immunohistochemistry. Explore protocol enhancements, troubleshooting strategies, and learn how the latest research on intestinal barrier dysfunction leverages this reagent for high-impact experimental clarity.

• Tamsulosin in Translational Biology: Precision Dosing and Pr

  2026-07-03

  Explore the advanced pharmacology and translational impact of Tamsulosin, a selective α₁A-adrenergic receptor antagonist, in urological and smooth muscle research. This article reveals how precision dosing and new biomarker data change practical assay design, offering unique guidance for research beyond standard protocols.

• AP1903: Precision FKBP-Binding Ligand for Conditional Cell A

  2026-07-02

  AP1903 enables nanomolar-precision control over FKBP fusion proteins, powering apoptosis pathway research and conditional cell ablation with unprecedented specificity. Its compatibility with multiplexed, high-throughput workflows distinguishes it as the gold standard for synthetic biology and functional genomics.

• Hypoxia-Activated Photomolecular Glues: Advancing Tumor Sele

  2026-07-02

  This article examines the development and validation of a hypoxia-activated photomolecular glue (BNNC) designed to synergistically degrade Cyclin K and enhance phototherapeutic efficacy in cancer cells. The study's innovation lies in its tumor-specific activation and dual-action mechanism, which together improve antitumor selectivity and therapeutic outcomes with minimized off-target toxicity.

• Cediranib (AZD2171): Precision Workflows in Cancer Research

  2026-07-01

  Cediranib (AZD2171) from APExBIO enables exceptionally precise inhibition of VEGFR signaling, powering advanced angiogenesis assays and mechanistic studies in oncology. This guide synthesizes recent innovations and troubleshooting insights to help researchers maximize reproducibility and data quality with Cediranib in in vitro cancer models.

• DAPT (GSI-IX) in Notch Pathway Research: Protocols & Insight

  2026-07-01

  DAPT (GSI-IX) empowers researchers to selectively dissect γ-secretase and Notch signaling with high precision, supporting robust experimental workflows in neurodegeneration, cancer, and vascular biology. This article delivers actionable protocols, troubleshooting guidance, and translational research strategies, grounded in recent angiogenesis studies and enhanced by APExBIO’s quality assurance.

• Diclofenac: Non-Selective COX Inhibitor in Intestinal Organo

  2026-06-30

  Diclofenac empowers translational inflammation and pharmacokinetic research using hiPSC-derived intestinal organoids, bridging the gap between bench models and human relevance. This article details optimized workflows, troubleshooting insights, and APExBIO's product advantages for cyclooxygenase inhibition assays in next-generation in vitro systems.

• Protease Inhibitor Cocktail EDTA-Free: Powering Reliable Pro

  2026-06-30

  Protect labile proteins from degradation with the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO), engineered for maximal compatibility with sensitive phosphoprotein workflows and immunoassays. This guide reveals hands-on protocols, advanced troubleshooting, and the latest experimental insights, ensuring data integrity from bench to publication.

• Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Technical Use Guide

  2026-06-29

  The Cy3 Goat Anti-Rabbit IgG (H+L) Antibody addresses the challenge of sensitive, specific detection of rabbit IgG in fluorescence-based immunoassays, including immunofluorescence, IHC, and ICC. It is not suitable for use with non-rabbit primary antibodies or for diagnostic applications.

• A23187, Free Acid: Reframing Calcium Ionophore Strategy in T

  2026-06-29

  Explore how A23187, free acid, a benchmark calcium ionophore, is redefining strategies for translational research through mechanistic insight and protocol optimization. This article bridges cutting-edge in vitro methodologies with actionable guidance for drug discovery and systems biology, drawing on authoritative sources and APExBIO’s proven solutions.

• Syringin Sensitizes RCC to Sunitinib via EGFR/PI3K/Akt Inhib

  2026-06-28

  This article examines a recent study identifying Syringin as a bioactive natural product that inhibits renal cell carcinoma (RCC) cell growth and enhances sensitivity to sunitinib by modulating the EGFR/PI3K/Akt pathway. The findings highlight mechanistic advances and practical implications for overcoming drug resistance in RCC using natural compound approaches.

• Elevating Cell Viability Assays: Translational Insights with

  2026-06-27

  This thought-leadership article explores the mechanistic and strategic dimensions of dual-fluorescence live-dead cell staining, contextualizing the APExBIO Live-Dead Cell Staining Kit within advanced translational workflows—from biomaterial evaluation to diabetic wound healing. Drawing on recent advances in hydrogel therapeutics and robust protocol recommendations, the article bridges fundamental viability assessment with new frontiers in regenerative medicine.

• Protease Inhibitor Cocktail EDTA-Free: Optimizing Protein Wo

  2026-06-26

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) from APExBIO delivers unmatched protein preservation in workflows sensitive to divalent cations. Its robust, EDTA-free formulation ensures compatibility with phosphorylation analysis and multi-protein assays—empowering researchers to achieve high-fidelity results where conventional protease inhibitors fall short.

7796 records 8/520 page Previous Next First page 上5页 678910 下5页 Last page